Prolonged hypothermic machine perfusion enables daytime liver transplantation - an IDEAL stage 2 prospective clinical trial.
Brüggenwirth IMA, Lantinga VA, Lascaris B, Thorne AM, Meerdink M, de Kleine RH, Blokzijl H, van den Berg AP, Reyntjens KMEM, Lisman T, Porte RJ, de Meijer VE; DHOPE-PRO Trial Investigators.
Brüggenwirth IMA, et al.
EClinicalMedicine. 2024 Jan 5;68:102411. doi: 10.1016/j.eclinm.2023.102411. eCollection 2024 Feb.
EClinicalMedicine. 2024.
PMID: 38235423
Free PMC article.